Pharmacological Effect of α-Glucosidase Inhibitor Voglibose in a Novel Obese Diabetic Model

Journal Title: Journal of Pharmaceutical Research International - Year 2014, Vol 4, Issue 23

Abstract

Aim: This study was conducted to investigate the preventive or therapeutic effect of α-glucosidase inhibitor voglibose in a new model rat, Spontaneously Diabetic Torii-Leprfa (SDT fatty) rat, which is a novel type 2 diabetic rat showing obesity, hyperglycemia and hyperlipidemia from a young age. Place and Duration of Study: Niigata University and JT Central Pharmaceutical Research Institute, between January and August 2011. Methodology: The present study was designed to the preventive and therapeutic effect of voglibose by administering (0.3, 1 mg/kg) voglibose as a dietary admixture to SDT fatty rats from 5 to 11 and 14 to 20 weeks of age, respectively. Results: In the examination of preventive effect, the obtained biochemical results show that voglibose decrease glucose level significantly in dose-dependent manner within 5-11 weeks of age. In voglibose-treated rats at 11 weeks of age, the histopathological pancreatic changes, such as vacuolation and irregular boundaries in islets, were improved. On the other hand, in the examination of therapeutic effect, voglibose improved the hyperglycemia only at a dose of 1 mg/kg within 16-20 weeks of age. Conclusion: Voglibose showed both preventive and therapeutic effects for diabetes in female SDT fatty rats. The SDT fatty rat is a useful model for development of anti-diabetic agents.

Authors and Affiliations

T. Ohta, Y. Kemmochi, K. Miyajima, M. Shinohara

Keywords

Related Articles

Potential Interactions of Herbal Extracts of St. John´s Wort with Metabolites of Diazepam in an Organotypical Sandwich Culture of Primary Porcine Hepatocytes

Extracts of St. John’s Wort (Hypericum perforatum) are known to cause interactions with certain conventional drugs. Herein, we focus on two clinically relevant concepts. First, St. John´s Wort has been used by people of...

Formulation and Evaluation of Ezetimibe Liquisolid Tablets: An Approach to Enhance the Dissolution Rate

Background and the Purpose of the Study: Liquisolid compacts’ using poorly water soluble drugs is considering as one of the novel pharmaceutical formulation technologies to improve the dissolution rate. This study was in...

Anthelminthic Activity of Annona reticulata Seed Extracts

Aims: To evaluate the anthelminthic activity of Annona reticulata seeds extracts against Pheretima posthuma. Study Design: Helminth infections have tormented humans and animals for thousands of years. The indiscriminat...

Phytomedicines of Sickle Cell Crisis in Mezam Division, Cameroon: Preventive and Curative Cares

Background: The aim of this study was to survey the Mezam Division of Cameroon, with a view to documenting how the population of that area treat sickle cells disease using medicinal plants, and to determine the need for...

Biological Activities of Nitro Steroids

The present review describes the biological activities of synthetic nitro steroids. More than fifty biologically active nitro steroids showed an analeptic, antineoplastic, anesthetic, neuroprotector, immunosuppressant, d...

Download PDF file
  • EP ID EP344453
  • DOI 10.9734/BJPR/2014/13553
  • Views 95
  • Downloads 0

How To Cite

T. Ohta, Y. Kemmochi, K. Miyajima, M. Shinohara (2014). Pharmacological Effect of α-Glucosidase Inhibitor Voglibose in a Novel Obese Diabetic Model. Journal of Pharmaceutical Research International, 4(23), 2622-2630. https://www.europub.co.uk/articles/-A-344453